Androgen receptor signaling‐targeted therapy and taxane chemotherapy induce visceral metastasis in castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Androgen receptor signaling‐targeted therapy and taxane chemotherapy induce visceral metastasis in castration‐resistant prostate cancer

Published:2020-10-13 Issue:1 Volume:81 Page:72-80
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Iwamoto Hiroaki¹^ORCID,Izumi Kouji¹^ORCID,Shimada Takashi¹,Kano Hiroshi¹,Kadomoto Suguru¹,Makino Tomoyuki¹^ORCID,Naito Renato¹^ORCID,Yaegashi Hiroshi¹,Shigehara Kazuyoshi¹,Kadono Yoshifumi¹,Mizokami Atsushi¹^ORCID

Affiliation:

1. Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science Kanazawa University Kanazawa Ishikawa Japan

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24082

Reference30 articles.

1. Cancer statistics, 2019

2. Global cancer statistics, 2012

3. A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015

4. Prostate-Cancer Mortality at 11 Years of Follow-up

5. Recent Time Trends in the Epidemiology of Stage IV Prostate Cancer in the United States: Analysis of Data From the Surveillance, Epidemiology, and End Results Program*

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies;Journal of Clinical Medicine;2024-01-27

2. Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa;Cancers;2024-01-24

3. Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis;Journal of Urology;2023-09

4. Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents?;Anticancer Research;2023-02-28

5. Analysis of Risk Factors for Early Progression of Prostate Cancer After Initial Endocrine Therapy;Journal of Cancer;2023